EW Edwards Lifesciences Corporation
Healthcare$87.86+0.00%OpenMarket Cap: $50.59B
As of 2026-05-26
Valuation
P/E (TTM)
42.26
PEG
—
P/B
4.81
P/S
7.84
EV/EBITDA
33.19
DCF Value
$61.72
FCF Yield
2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.0%
Operating Margin
27.6%
Net Margin
17.3%
ROE
10.6%
ROA
8.2%
ROIC
12.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.65B | 78.2% | $514.7M | $380.7M | $— | — |
| Q4 null | $1.57B | 78.3% | $370.3M | $91.2M | $— | — |
| FY null | $6.07B | 78.1% | $1.64B | $1.07B | $— | — |
| Q3 null | $1.55B | 77.9% | $425.1M | $291.1M | $— | — |
| Q2 null | $1.53B | 77.6% | $430.9M | $329.8M | $— | — |
| Q1 null | $1.41B | 78.7% | $394.8M | $358.0M | $— | — |
| Q4 null | $1.39B | 78.9% | $312.6M | $385.6M | $— | — |
| FY null | $5.44B | 79.5% | $1.38B | $4.17B | $— | — |
| Q3 null | $1.35B | 80.6% | $350.6M | $3.07B | $— | — |
| Q2 null | $1.39B | 78.5% | $364.7M | $363.7M | $— | — |
| Q1 null | $1.33B | 78.2% | $355.5M | $351.9M | $— | — |
| Q4 2023 | $1.27B | 80.2% | $356.7M | $369.9M | $0.61 | — |